AbbVie

AbbVie (NYSE:ABBV) is a global research-based biopharmaceutical company officially established on January 2, 2013, spun off from Abbott Laboratories. AbbVie combines cutting-edge biotechnology with a century-long heritage of focus, passion, and expertise, along with its organizational structure. With its specialized technology, dedicated employees, and unique approach to innovation, AbbVie aims to develop and promote advanced treatments to address some of the most challenging diseases worldwide.